Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Personal Disord. 2015 Jan;6(1):81–87. doi: 10.1037/per0000091

Table 1.

Estimated percentage of adults with borderline personality disorder (BPD) in the NESARC excluded from typical clinical trials of pharmacological treatments for BPD by traditional exclusion criteria.

Borderline personality disorder patients (n = 2,231)


Exclusion variable* % (N) 95% CI



Psychosis 5.22 (121) 4.11 – 6.60

Currently/past 12 months’ alcohol or drug abuse or dependence 29.87 (618) 27.48 – 32.37

Lifetime bipolar disorder 29.71 (663) 27.39 – 32.14

Current major depressive episode 19.25 (440) 17.38 – 21.25

Significant suicidal risk 2.16 (37) 1.43 – 3.25

Significant medical condition 32.54 (749) 30.19 – 34.99

Pregnancy/breastfeeding 1.16 (24) 0.71 – 1.90

Currently taking any psychotropic NA NA

Exclusion by at least one criterion 75.91 (1,692) 73.60 – 78.09

Percentages are weighted values.

*

Derived from the review of 21 pharmacological efficacy trials (method described in the paper).

Abbreviations: CI = confidence interval, NA = not available in NESARC, NESARC = National Epidemiologic Survey on Alcohol and Related Conditions.